About Me
Conditions and Treatments
Conditions
- back injury
- breathing disorder during sleeping
- epileptic seizures
- muscle disease
- spinal injury
Treatments
- electroencephalography
- electromyography
- evoked potentials testing
Learn more about conditions we treat at NYU Langone:
Back Pain in Adults , Degenerative Disc Disease in Adults , Failed Back Surgery Syndrome in Adults , Herniated Disc in Adults , Neck Pain in Adults , Spinal Stenosis in Adults , Spondylolisthesis in Adults , Spondylolysis in Adults , Spine Compression Fractures in Adults , Obstructive Sleep Apnea in Adults , Epilepsy & Seizure Disorders in AdultsCredentials
Positions
- Clinical Assistant Professor, Department of Neurology at NYU Grossman School of Medicine
Board Certifications
- American Board of Psychiatry & Neurology (Clinical Neurophysiology), 1996
- American Board of Psychiatry & Neurology - Neurology, 1995
Education and Training
- Fellowship, Hospital For Joint Diseases, Neurophysiology, 1995
- Residency, NYU Medical Center, Neurology, 1994
- MD from Sun Yat-Sen University, 1983
Is this your profile?
Edit profileInsurance Plans Accepted
This provider accepts the following insurance plans.
- Affinity
- Cigna PPO
- Fidelis Child Health
- Fidelis Family Health
- Fidelis Medicare
- GHI
- HIP Medicaid
- HealthFirst
- Healthnet
- Local 1199 PPO
- Medicare
- MetroPlus Child Health
- MetroPlus Exchange Plans
- MetroPlus Family Health
- MetroPlus Medicaid
- MetroPlus Medicare
- NY Medicaid
- NYS Health Insurance Plan - The Empire Plan
- Oxford Liberty
- Oxford Medicare
- Railroad Medicare
- UnitedHealthcare Community & State Plan
- Visiting Nurse Service (VNS) Medicare
- WellCare Family Health
- WellCare Medicaid
- WellCare Medicare
- Wellcare Exchange
- Workers Comp
Locations and Appointments
212 Garretson Avenue, Staten Island, NY 10305
Research Academic Contact
Academic office
301 East 17th Street
Fifteenth Floor
New York, NY 10003
Phone
718-980-5000
Publications
-
Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480 (BMC Cancer, (2021), 21, 1, (321), 10.1186/s12885-021-08056-4)
Huang, C -C; Liu, F -R; Feng, Q; Pan, X -Y; Song, S -L; Yang, J -LBMC cancer. 2021 December; 21(1):
-
RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
Huang, C -C; Liu, F -R; Feng, Q; Pan, X -Y; Song, S -L; Yang, J -LBMC cancer. 2021 December; 21(1):
-
Wang, Y Y; Wang, T; Yu, H; Xu, W M; Yu, T; Song, S L; Cui, J; Yang, J L
Zhonghua bing li xue za zhi = Chinese journal of pathology. 2020 Nov 08; 49(11):1163-1168